Overview

Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily

Status:
Unknown status
Trial end date:
2017-09-30
Target enrollment:
Participant gender:
Summary
Exploratory trial to evaluate the efficacy and safety of D565H twice daily versus D565 once daily.
Phase:
Phase 2
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
Latanoprost